Results 171 to 180 of about 375,177 (211)

CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders. [PDF]

J Clin Invest
Bai X, Miao D, Xiao S, Qiu D, St-Arnaud R, Petkovich M, Gupta A, Goltzman D, Karaplis AC.   +8 more
europepmc   +1 more source

Research hotspots and trends in the field of immune checkpoint inhibitors (ICIs) for cervical cancer: A bibliometric study from 2014 to 2024. [PDF]

Hum Vaccin Immunother
Shen C, Zhang J, Zhang G, Luo H, Zhang S, Yuan Q, Xu W, Wang W, Miao L.   +8 more
europepmc   +1 more source

Self-citation pattern among world's top 2 % of the scientists. [PDF]

Heliyon
Abdalla BA, Mustafa AM, Fattah FH, Kakamad FH, Omar SS, Salih AM, Muhialdeen AS, Ahmed JO, Bapir R, Mohammed SH, Mohammed KK, Baba HO, Ahmed SM, Mustafa SM, Najar KA.   +14 more
europepmc   +1 more source

Global research trends on physical education practices: a bibliometric analysis and science-mapping study. [PDF]

Front Sports Act Living
Hernández-González V, Carné-Torrent JM, Jové-Deltell C, Reverter-Masia J.   +3 more
europepmc   +1 more source

Evidence-Based Bibliometric Analysis of Acupuncture in Functional Dyspepsia: Clinical Efficacy and Research Trends. [PDF]

J Multidiscip Healthc
Wei X, Jia X, Su X.
europepmc   +1 more source

Quantifying the dynamics of peak disruption in scientific careers. [PDF]

Sci Rep
Li M, Livan G, Righi S.
europepmc   +1 more source

Knowledge mapping of tumor microenvironment for breast cancer: a bibliometric analysis from 2014 to 2023. [PDF]

Front Immunol
Jiang D, Wen P, Zhang S, Zhang N, Shao Q, Wang G, Wang L, Li S, Qin Y, Qu F, Zeng X.   +10 more
europepmc   +1 more source

Mapping the rapid growth of multi-omics in tumor immunotherapy: Bibliometric evidence of technology convergence and paradigm shifts. [PDF]

Hum Vaccin Immunother
Dong H, Wang X, Zheng Y, Li J, Liu Z, Wang A, Shen Y, Wu D, Cui H.   +8 more
europepmc   +1 more source

Patent value prediction in biomedical textiles: A method based on a fusion of machine learning models. [PDF]

PLoS One
He Y, Deng K, Han J.
europepmc   +1 more source

Research Trends of Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer: A Bibliometric Analysis. [PDF]

Drug Des Devel Ther
Chang X, Wang C, Zhang L.
europepmc   +1 more source